Hepatic PSMA-Avid Postradiation Inflammation

Patrick Silveira; Aria Razmaria; Randy Yeh

doi:10.1097/RLU.0000000000005257

Hepatic PSMA-Avid Postradiation Inflammation

Clin Nucl Med. 2024 May 2. doi: 10.1097/RLU.0000000000005257. Online ahead of print.

Authors

Patrick Silveira¹, Aria Razmaria, Randy Yeh

Affiliation

¹ From the Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.

PMID: 38693645
DOI: 10.1097/RLU.0000000000005257

Abstract

A 62-year-old man with de novo large volume metastatic prostate cancer to the bone, liver, and nodes status post multiple lines of therapy including external beam radiation to T12-L2 approximately 13 months prior underwent 68Ga-PSMA PET/CT to determine eligibility for 177Lu-PSMA therapy. 68Ga-PSMA PET/CT demonstrated tracer-avid osseous and nodal lesions consistent with metastases. In addition, regional geographic tracer avidity was seen in the midline left hepatic lobe associated with capsular retraction and demonstrated no FDG avidity on subsequent imaging, probably inflammatory related to prior radiation to T12-L2.